Inhaltsseite: Home

ZKB Mini-Future Short auf Novo Nordisk -B-, Open End
Novo Nordisk A/S

ISIN: CH1305144078 Security: 130514407 Symbol: INOQ7Z Life cycle
Secondary market

Bid Price 0.44

Ask Price 0.45

Currency CHF

Exchange SIX Structured Products

Volume 75'000.00

Volume 75'000.00

Date/time (delayed) 31.05.2024 04:54:55

Sell Buy 

Product Download

Security PDF for download Publication date
Termsheet 31.05.2024
Key Information Document DE 31.05.2024
Key Information Document EN 31.05.2024
Key Information Document FR 31.05.2024
Key Information Document IT 31.05.2024

Price data

  Bid Ask
Price 0.44 0.45
Volume 75'000.00 75'000.00
Date/time 31.05.24 16:54 31.05.24 16:54

Current data

Last price paid 0.45
Change -6.25% [ -0.03 ]
Last traded volume n.a. Unit
Cumulative volume n.a. Unit
Date/time 31.05.2024 17:20

Life cycle

Fixingn.a.
Settlement date12.03.2024
Last tradingn.a.
Final fixingn.a.
Currency redemptionCHF

Performance

Perf. since issue -7.29%
Year to date (YTD) n.a.
1 month -10.00%
3 months n.a.
1 year n.a.
3 years n.a.

Key figures on issue

Issue price0.48
Underlying price on issue915.80
Premium0.01%
Premium p.a.n.a.
Leveragen.a.
Implied volatilityn.a.

Reference data

ISIN CH1305144078
Symbol INOQ7Z
Security 130514407
Exchange SIX Structured Products
Currency CHF
Expiry n.a.
Underlying Novo Nordisk -B-, DK0062498333
Underlying ISIN DK0062498333
Funding level 1091.598200
Stop-loss level 1048.226800
Distance to stop-loss level 13.04%
Long/Short type Short
Subscription ratio 50.00
Issuer Zürcher Kantonalbank
Exercise type n.a.
Minimum execution n.a.
Value day 08.03.2024

Key figures

Premium 0.55%
Premium p.a. n.a.
Leverage 5.47
Moneyness in-the-money
Leverage n.a.
Delta n.a.
Intrinsic value 164.298200
Break-even n.a.
SSPA value at risk n.a.
SSPA risk rating n.a.

Product type

SSPA derivative category Leverage
SSPA code Mini future (2210)

Ajax loading